Split Luciferase Reporter System for Specific Cell Tracking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PET/SPECT reporter genes for tracking cells in gene and cell therapies are limited by their size, ease of cloning, and expression specificity, as well as short imaging windows due to natural expression in non-target tissues and tracer efflux.

Innovation Solution

A novel reporter gene system comprising a fusion protein with a transmembrane domain and a split luciferase reporter domain that associates with a high-affinity reporter peptide, allowing for both PET/SPECT and bioluminescence imaging, enabling specific and prolonged tracking of cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the NIS reporter gene is used for PET/SPECT imaging, then imaging capability is provided, but the gene is naturally expressed in multiple tissues causing non-specific signal and tracer efflux

Engineering Contradiction:
Improveimaging specificityVSAvoidbackground signal from non-target tissues
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The reporter system is divided into two separate components: a membrane-anchored reporter protein expressed in therapeutic cells and a circulating radiolabeled peptide probe. This segmentation allows the reporter to be selectively displayed on cell surfaces while the probe circulates freely, enabling specific binding only at the target location and eliminating background signal from tissues expressing the reporter gene.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention extracts the reporter function from the NIS system by using a custom-designed membrane-anchored protein domain that binds specifically to the radiolabeled peptide. This extracted reporter system removes the harmful non-specific binding characteristic of NIS while retaining the imaging capability.

Inventive Principle:
Principle #2Taking out (Extraction)

2Reliability

If the NIS reporter gene is used, then imaging is enabled, but the gene is relatively long making cloning difficult

Engineering Contradiction:
Improveimaging capabilityVSAvoidgene size for cloning
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention extracts only the essential reporter function from the full NIS gene, using a minimal membrane-anchored protein domain (approximately 100-200 amino acids) that provides the necessary binding capability. This extracted fragment is significantly smaller and easier to clone into therapeutic vectors while maintaining imaging functionality.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The reporter system is segmented into a small membrane-anchored protein component and a separate radiolabeled peptide, allowing the genetic material to be minimized to only the essential binding domain while the imaging function is provided by the small peptide probe.

Inventive Principle:
Principle #1Segmentation

3Reliability

If NIS reporter gene is used, then cell tracking is possible, but tracer probes are not trapped and can efflux resulting in short imaging windows

Engineering Contradiction:
Improvecell tracking capabilityVSAvoidimaging window duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The membrane-anchored reporter protein is pre-positioned on the cell surface before administration of the radiolabeled peptide probe. This preliminary anchoring ensures that when the probe circulates, it binds immediately and specifically to the reporter, creating a stable complex that remains trapped at the target location, thereby extending the imaging window.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The membrane-anchored reporter protein acts as an intermediary that captures and holds the radiolabeled peptide probe on the cell surface. This intermediary mechanism prevents probe efflux and ensures prolonged retention of the tracer, extending the imaging window compared to direct NIS-mediated trapping.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system provides highly specific and prolonged imaging capabilities, allowing for effective monitoring of cell therapies like CAR T-cell therapy, with minimal background signal and easy cloning into therapeutic vectors, enhancing diagnostic and prognostic imaging.

Implementation Method 1

the reporter domain comprises, preferably consists of, the large polypeptide subunit of a split luciferase, and wherein said reporter peptide comprises, preferably consists of, the small peptide subunit of said split luciferase, wherein both subunits associate by complementation to assemble into a (preferably luminescent) luciferase complex

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Implementation Method 2

a reporter peptide labeled with a radiolabel; wherein said reporter domain comprises, preferably consists of, the large polypeptide subunit of a split luciferase, and wherein said reporter peptide comprises, preferably consists of, the small peptide subunit of said split luciferase

Methodology Applied
Scientific EffectRadioactive Tracing: Radioactive Tracing

Data Source

PatentUS20230211023A1Reporter system for radionuclide imaging
Publication Date: 2023.07.06 ERASMUS UNIV MEDICAL CENT ROTTERDAM ERASMUS MC
  • US20230211023A1 patent drawing
  • US20230211023A1 patent drawing
  • US20230211023A1 patent drawing

AI summary

The present invention provides a reporter system comprising (i) a gene expression construct for expression in a cell of a reporter gene, said reporter gene encoding a fusion protein comprising a transmembrane domain fused in-frame to a reporter domain, wherein said transmembrane domain upon insertion of the fusion protein into the cell membrane anchors the fusion protein in the cell membrane while expressing the reporter domain at the cell surface, and (ii) a reporter peptide labeled with a radiolabel, wherein said reporter domain comprises the large polypeptide subunit of a split luciferase, and wherein said reporter peptide comprises the small peptide subunit of said split luciferase, wherein both subunits associate by complementation to assemble into a luciferase complex.